Key Highlights
- China-manufactured Tesla vehicles reached 79,478 deliveries in April, up 36% annually
- Monthly deliveries declined 7.2% versus March but significantly exceeded prior-year figures
- Chinese Full Self-Driving authorization timeline pushed back to third quarter from initial first-quarter projections
- Company executives divested more than 80,000 shares totaling approximately $30.8 million over three months
- Wall Street consensus lands at “Hold” with $398.42 average target price
The electric vehicle pioneer’s Shanghai manufacturing operations recorded a robust 36% year-over-year increase in April deliveries, extending its positive growth trajectory to half a year. Production from the Chinese facility totaled 79,478 vehicles, encompassing both domestic sales and international shipments to European territories and additional markets.
While this represents a sequential decrease of 7.2% compared to March’s 85,670-unit output, the year-over-year metrics paint a considerably brighter picture for the EV manufacturer.
TSLA trading began Thursday at $398.75, posting approximately 2.4% gains for the session. The equity trades within a 52-week bandwidth of $271.00 to $498.83, supporting a $1.50 trillion market capitalization.
Tesla’s competitive landscape in China has faced significant headwinds throughout the previous twelve months. The manufacturer witnessed nearly 50% erosion of its European market position in 2025, while domestic Chinese competitors offering more affordable alternatives maintained consistent pressure.
However, April’s performance metrics indicate potential stabilization. The company experienced sales momentum across multiple European territories during the period, particularly in Swedish, French, and Danish markets.
Heightened European battery electric vehicle demand received support from elevated petroleum prices connected to U.S.-Iran geopolitical tensions.
Autonomous Driving Authorization Postponement Complicates Outlook
A significant challenge affecting the Chinese market narrative involves Full Self-Driving technology. Tesla currently anticipates securing complete FSD authorization in China during the third quarter, representing a delay from the initial first-quarter timeline.
Chief Financial Officer Vaibhav Taneja acknowledged this postponement during the company’s April quarterly earnings discussion. FSD authorization represents a critical competitive advantage in China, especially among affluent consumer segments.
European regulatory authorities have similarly expressed reservations regarding the autonomous technology, based on correspondence examined by Reuters.
To maintain competitive positioning within China, Tesla is purportedly engineering a more affordable compact SUV for domestic production. This strategic initiative directly addresses the proliferation of budget-friendly Chinese vehicle offerings.
Aggregate retail new energy vehicle sales across China reached 1.22 million units during April, representing 7% annual growth, according to China Passenger Car Association data.
BYD, Tesla’s primary Chinese competitor, experienced a 15% annual sales contraction in April with 314,100 units delivered.
Executive Divestments and Cautious Analyst Posture
Regarding financial performance, Tesla delivered first-quarter earnings per share of $0.41, surpassing the $0.39 analyst projection. Revenue totaled $22.39 billion, marginally below the $22.96 billion consensus forecast.
Revenue demonstrated 15.8% year-over-year expansion. First-quarter 2025 results showed $0.27 earnings per share.
Executive stock sales have accelerated recently. Board member Kathleen Wilson-Thompson liquidated 26,409 shares on April 30 at a $378.11 average execution price, generating approximately $10 million in proceeds. This transaction reduced her ownership position by 35.3%.
Throughout the preceding 90-day period, company insiders collectively sold 80,213 shares valued at roughly $30.85 million.
Regarding institutional activity, Gateway Investment Advisers expanded its Tesla holdings by 0.5% during the fourth quarter, acquiring 2,279 additional shares to establish a 498,845-share position worth approximately $224.3 million.
Wall Street analyst perspectives remain divided. Among 41 professionals tracking the stock, 19 recommend buying, 17 suggest holding, and 5 advise selling. The consensus price objective stands at $398.42.
Truist Financial reduced its target from $438 to $400 while maintaining a Hold recommendation on April 2. Bank of America holds a Buy rating with a $460 price target.
